Mr. Jess Roper's most recent trade in Revelation Biosciences Inc was a trade of 32,011 Common Stock done . Disclosure was reported to the exchange on Aug. 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revelation Biosciences Inc | Mr. Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2026 | 32,011 | 44,839 | - | 0 | Common Stock | |
| Revelation Biosciences Inc | Mr. Jess Roper | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.85 per share. | 03 Feb 2026 | 1,591 | 12,828 | - | 1.8 | 2,943 | Common Stock |
| Revelation Biosciences Inc | Mr. Jess Roper | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.85 per share. | 03 Feb 2026 | 1,591 | 12,828 | - | 1.8 | 2,943 | - |
| Revelation Biosciences Inc | Mr. Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.90 per share. | 08 Jan 2026 | 41,981 | 57,667 | - | 0.9 | 37,783 | Common Stock |
| Revelation Biosciences Inc | Mr. Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.90 per share. | 08 Jan 2026 | 41,981 | 57,667 | - | 0.9 | 37,783 | - |
| Revelation Biosciences Inc | Mr. Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 1.28 per share. | 29 Oct 2025 | 15,625 | 15,686 | - | 1.3 | 20,000 | Common Stock |
| Revelation Biosciences Inc | Mr. Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 181 | 183 | - | 3.9 | 700 | Common Stock |
| Revelation Biosciences Inc | Mr. Jess Roper | Director | 14 Apr 2023 | 6,356 | 6,356 | - | - | Stock Option (Right to Buy) |